Trending News
News
News
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug Discovery
Investment to fund expansion of operations and progression of drug target pipeline.
News
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.
News
Drug Combo Prevents Stroke, Shows Promise for Clinic
Taking the clot-preventing drug clopidogrel along with aspirin may lower your risk of having a major stroke within the next 90 days following a TIA
News
Vaccine to One Hemorrhagic Virus Could Protect Against Others
Scientists report that antibodies made in response to a vaccine against one hemorrhagic fever virus—Junin—can successfully disarm one of its cousins, Machupo, for which there’s currently no vaccine.
News
Snail Memory Transplant a Success
Biologists report they have transferred a memory from one marine snail to another
News
Combating Cancer by Targeting Sugar Receptors
Globally, cancer is the second leading cause of death, also because the efficiency of chemotherapeutics is inadequate due to poor delivery to the tumor. Prof. Olivia Merkel and her team develop targeted nanocarrier systems to increase the delivery rates of therapeutic formulations and their specific uptake into the target cells.
News
'Universal Antibodies' Disarm Various Pathogens
Based on the sugar structures on their surface, bacteria can be classified in subgroups. As a rule, an antibody eliminates only one subgroup and does not protect against other microbes. However, in studies with the bacterium Klebsiella pneumoniae, researchers have now been the first to find that the immune system also produces antibodies that recognize and neutralize various microorganisms.
News
Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu Vaccine
Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to vaccine development in the field of infectious diseases, announces that Innovate UK, the UK’s innovation agency, has awarded the company a grant of £979,318 to progress its universal flu vaccine programme through preclinical development.
News
Tech Solution Speeds Up Glycoprotein Research
A synthetic biology research team has combined cell-free protein synthesis and mass spectrometry to develop a new biotech technique that promises to accelerate research into protein therapies. The fruits of their labour could one day become the next defence against antibiotic-resistant supergerms or the next new drug.
News
CAR T Cell Therapy Shows Promise in Acute Myeloid Leukemia
The Food and Drug Administration has approved CAR T therapy products for adults with diffuse large B-cell lymphoma and pediatric and young adults suffering from acute lymphoblastic leukemia. Now, researchers at Moffitt Cancer Center are working to expand this revolutionary therapy to other cancers.
Advertisement